Osteochondral lesions of the talus (OLT) present a formidable treatment challenge to the orthopaedic surgeon. Historical carti lagerepairstrategiesoftenresultintheformationoffibro cartilage leading to suboptimal clinical results. With advances in regenerative medicine, modern surgical tech niques are diverse andemployautograft,allograftandtissueengineeredconstructs for cartilage repair. Fresh and parti culated juvenile allograft transplantation have become popular options in the United States.Worldwide,bothcellularandacellulartissueengineered constructs are utilized. In all cases, there is still debate as to the optimal cell source and scaffold material and only short term clinical results are available. This article will review these current as well as experimental techniques for cartilage repair of osteochondral lesions of the talus.
INTRODUCTION
Previously described as osteochondritis dissecans, osteo chondral fracture, transchondral fracture and osteo chondral defect, osteochondral lesion of the talus (OLT) refers to any pathology of the articular cartilage of the talus and corresponding subchondral bone. Osteochondral lesion of the talus is the preferred nomen clature; however, osteochondral lesion (OCL) of the talus is an acceptable alternative.
The poor intrinsic regenerative capacity of cartilage makes treating OLTs a particular challenge for ortho paedic surgeons. Historically, debridement and marrow stimu lation to encourage cartilage repair was the
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main stay of treatment. Unfortunately, this treatment often resulted in fibrocartilage formation leading to sub optimal clinical results. Innovations in cartilage repair have led to a plethora of modern surgical techniques; employing autograft, allograft and alternative cell sources for carti lage repair. Despite these recent advances, the paucity of comparative studies examining these techniques has led to a lack of consensus regarding surgical guidelines. This article will review the current techniques and supporting literature for surgical management of OLTs.
In general, operative treatment is indicated for lesions that remain symptomatic despite 3 to 6 months of nonoperative treatment or displaced OLTs of any chro nicity. Many operative techniques have been described to treat OLTs; we will classify these treatment strategies as cartilage repair, regeneration or replacement.
CARTILAGE REPAIR STRATEGIES

Marrow Stimulation
Marrow stimulation (microfracture) is typically used as the initial operative management after failed conservative treatment. By perforating the subchondral bone, marrow stimulation allows the migration of bone marrow proge nitor cells to infiltrate the lesion and attempt repair (Figs 1A to D). Unfortunately, the process typically yields a defect repaired with fibrocartilage, consisting of mainly type I collagen, instead of hyaline cartilage which is pri marily composed of type II collagen. The fibro cartilage formed from this procedure has been shown to be bio mechanically weaker than hyaline cartilage in the knee, 61 but this is believed to be a better alternative, regarding pain and function, than the exposed subchondral bone of the OLT.
Success rates for marrow stimulation range from 65 to 90%. 20, 42, 67, 69, 73, 75 Historically, microfracture was applied to all OLTs; however, modern literature has been beneficial in providing guidelines as to the most appropriate lesions for marrow stimulation. Size, patient age, OLT chronicity, associated joint degeneration, presence of subchondral cysts, and lesion location and contain ment have been studied as prognostic factors with varying amounts of evi dence regarding each charac teristic. weight bear using a figure of eight splint after an arthroscopic microfracture procedure. All patients had exce llent recovery with significant improvements in VAS and AOFAS anklehindfoot scores. Lee et al 50 recently conducted a prospective, randomized trial comparing early weightbearing at 2 weeks to a protocol of nonweightbearing for a 6 weeks period in patients treated with arthroscopic microfracture for small to medium sized OLTs. A total of 81 ankles with lesions less than 2.0 cm² were randomized to these two groups and followed for an average of 37 months. AOFAS, CAS, and ankle acti vity score (AAS) showed significant improvements from preoperative to final postoperative visits for both groups. None of the scores demonstrated a significant difference between the early weightbearing and nonweightbearing groups. Thus, early return to weightbearing status may be warranted.
Retrograde Drilling
In unique cases of talar lesions where the subchondral bone appears cystic but the overlying cartilage is intact, retrograde drilling without microfracture has been performed with excellent clinical outcomes. 25 The authors utilized a drill ranging from 7 to 9 mm in diameter to create a working portal to debride the lesion subchondrally. After removing the necrotic bone, the portal was back filled with an autologous cancellous bone cylinder in a pressfit manner. Open growth plates and those with first time surgical interventions were associated with better outcomes. In a recent feasibility study 43 (electronic, four patients were successfully treated with MRIguided retrograde drilling. In this study, a 0.23 tesla open configuration MRI system was used. Instrument tracking was performed using an infrared navigation system. The most edematous portion of the OLT was targeted and approached from an oblique anterolateral direction. The mean time of the procedure was 48 minutes.
CARTILAGE REGENERATION STRATEGIES Autologous Chondrocyte Implantation
Autologous chondrocyte implantation (ACI) is a staged procedure that often is used after failed conservative treatment or microfracture. 60 Ideal lesions should be focal and well circumscribed by a rim of intact cartilage. Hyaline cartilage is harvested during the first stage, usually from the anterior talus, 7 interchondylar notch or other nonweightbearing portion of the ipsilateral knee. 60 Typically, 200 to 300 mg of cartilage is harvested and then cultured for 3 to 8 weeks to increase the number of chondrocytes, which can then be stored for >1 year. 60 In a second procedure, the cells are delivered into the OLT and a periosteal patch from the tibia is sewn into place to cover the defect. ). Extensive subchondral cysts were bonegrafted at the time of implantation in six patients. They reported significant improvement in the AOFAS anklehindfoot score and Tegner activity score at a mean followup of 38 months. Nine of the 11 (82%) patients reported good or excellent results and stated they would have the surgery again. Unlike the results for microfracture, OLT size or presence of a cyst had no impact on outcome of ACI in this study. The authors did, however, discourage ACI for OLTs with a cartilage defect of > 400 mm 2 ) that showed significant improvement in the AOFAS ankle hindfoot score at mean of 63 months followup. It should be noted that the study included an undisclosed number of patients who failed previous attempts at microfracture or drilling.
Whittaker et al 81 followed 10 ACI patients for 4 years.
The mean size of these lesions was 1.95 cm 2 and eight of 10 patients had undergone prior arthroscopic debridement. Cartilage was harvested from the ipsilateral knee in all cases and 90% of the patients were 'pleased' or 'extremely pleased' with their final outcome. Secondlook arthroscopy was performed in nine patients at a mean of 13 months showing that all lesions were macroscopically filled. Five of these patients had biopsies. Osteochondral lesions of the talus frequently occur after ankle sprains and, thus, in an inflammatory environ ment. In these instances, the level of PGE 2 is increased, which leads to chondrocyte apoptosis and may lead to the differentiation of bone marrowderived cells to a fibroblastic phenotype. 56 Even the postsurgical joint microenvironment can have elevated levels of proinflammatory cytokines. 71 Therefore, Cadossi et al sought to alter the joint environment following BMDC implantation with a pulsed electromagnetic field in thirty patients. These patients were then randomized to serve as a control group or have the electromagnetic field applied for 4 hours a day for 60 days. Significantly, higher AOFAS scores were recorded at 6 and 12 months in the experimental group. At 60 days, 6 and 12 months followup, the experimental group had significantly lower pain. No significant difference was found in SF36 between group.
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CARTILAGE REPLACEMENT STRATEGIES Osteochondral Autograft Transfer
Osteochondral autograft transfer (OAT) techniques are designed to deliver hyaline cartilage to an osteochondral defect. For lateral lesions, this may be accomplished by using a temporary external fixation device. 64 Cartilage plugs can be harvested from a nonweightbearing portion of the ipsilateral knee, iliac crest, 54 Emre performed open mosaicplasty through a medial malleolar osteotomy on 32 patients. 22 Allograft was harvested from the lateral femoral condyle of the ipsilateral knee in all cases. Malleolar osteotomy was fixed with a screw in all cases and range of motion exercises were begun shortly after surgery with full weightbearing allowed at 6 weeks once radiographs confirmed bony union. The mean size of the lesion treated was 1.18 cm² (0.41.8) and stages ranged from lesions contained only in the cartilage to those full thickness defects containing subchondral cysts and avascular necrosis. At latest followup, mean AOFAS anklehindfoot scores increased from 59 to 88. At final followup, two patients (6.2%) experienced pain at the donor knee. The authors of this study concluded that mosaicplasty is a viable option for larger more advanced osteochondral lesions of the talus. osteochondral plugs were harvested from the ipsilateral talus. The largest graft size was 8 mm in diameter taken from either the medial or lateral talar facet. Significant improvement in the AOFAS anklehindfoot score was observed at a mean followup of 25 months. The most common complaint was minimal aching over the anterior aspect of the ankle with no patient reporting decreased ability to participate in activities of daily living or sports. Kreuz et al 46 reported on a series of 35 patients who under went ipsilateral talus articular facet osteochondral plug harvesting and implantation through a variety of approaches. No complications related to graft harves ting were seen and implantation was done via a medial malleolar osteotomy, a tibial wedge osteotomy or no osteo tomy. Each graft was up to 10 mm in diameter with two patients requiring multiple plugs. Significant improve ment in AOFAS anklehindfoot scores was seen at 48.9 months. The best results were seen in those patients who did not require an osteotomy.
Often times, larger lesions may need more than one graft to fill the defect. In a study of 28 patients who underwent autologous osteochondral transplantation, 38 fourteen patients with a mean defect size of 208 ± 54 mm 2 were treated with a double plug autograft transplantation. They were matched by age and sex to a control cohort of 28 patients who underwent a single plug transplantation for a mean defect size of 74 ± 26 mm 2 . All patients with single and doubleplug allografts had singficant increases in FAOS and SF12 scores, though there was no difference between the groups. Mean MOCART scores did not show any significant difference between groups. The authors conclude that, in the intermediate term, doubleplug allo grafts are as effective as single plug allografts in treating larger talar OLTs.
Osteochondral Allografts
Osteochondral allografting is typically performed on large talar shoulder lesions (Figs 2A to H) . The grafts are obtained from human cadavers from licensed tissue banks. They may be fresh or freshfrozen, although we recommend fresh grafts. The tissue bank delivers the entire talus that has been sizematched based on recipient radiographic parameters. Advantages of using osteochondral allografts include a single stage procedure with the ability to restore multiple dimensions of cartilage loss, treat large lesions, and eliminate donor site morbidity in the knee. Disadvantages include disease transmission, failure of the graft to incorporate and necessity for intra articular hardware placement. Very few studies exist on osteochondral allografting for OLTs. Gross ) with a mean depth of 7 mm (320 mm). All lesions had at least one dimension greater than or equal to 10 mm. The lesions were accessed via an open approach in 12 cases, an arthroscopic approach in three cases, and through an extended portal open approach in nine cases. Bone grafting was performed on lesions deeper than 5 mm. The mean postoperative 100 mm VAS for pain was 24 (093) and the mean AOFAS anklehindfoot score was 85 (23100). The mean foot and ankle ability measure (FAAM) for activities of daily living was 55.1 (5258) and the mean FAAM for sports was 63.4 (5275). The mean postoperative SF12 physical composite score was 46.4 (4251). The authors note that these outcomes scores are similar to published reports on patients who were treated with bone marrow stimulation, autologous chondrocyte implantation, and matrixinduced autolgous chondrocyte implantation. Five patients required reoperation to remove symptomatic osteotomy hardware. One patient required an additional procedure to treat anterior impingement. At the time of two of these procedures, the juvenile cartilage was minimally debrided. Additionally, during three reoperations, the International Cartilage Repair Society (ICRS) cartilage repair assessment (protocol A) was used to assess the repair tissue. The three lesions were assessed at grade 2 (nearly normal repair). There was one partial graft delamination (~25% of the graft) that was diagnosed at 16 months. The original lesion size of this patient was 180 mm 2 .
Kruse et al 47 presented one case of arthroscopically performed PJCAT to an OLT in a 30yearold female with a full thickness posteromedial lesion that measured 7 × 5 mm. At 2 years following surgery, the patient was found to pain free with no activity limitations. Bleazey and Brigido 9 retrospectively reported on a series of seven patients treated with a cylindrical allo graft plug and PJCAT. The surgical technique was performed through a medial malleolar or fibular osteotomy in all patients. The lesion was assessed and then a sizematched reamer was used to ream past the subchondral plate into the cancellous bone. A cylindrical sponge allograft of matched diameter was then inserted and recessed to the level of the subchondral plate. Next, ex vivo, the particulated cartilage and fibrin glue were mixed into a sizematched mold to form the graft. Next the graft was secured with additional fibrin glue. All patients demonstrated significant improvement in each category of a custom 10point scale that assessed ability to ambulate up stairs, down stairs and four city blocks. The greatest improvement was in the ability to walk four city blocks. All patients would have the surgery performed again. However, all patients were followed for only 6 months. Indications for this procedure technique have yet to be completely defined. However, Giza et al 32 state that the ideal patient is a young patient (less than 50 years old) who has a failed a previous microfracture. The authors use PJCAT for lesions that have failed previous debridement and marrow stimulation techniques or on primary lesions that are greater than 15 mm in diameter.
We are moving toward performing the majority of PJCATs arthroscopically even in cases when bone graft is needed. 1 However, in cases with larger defect that would require significant bone grafting, the authors prefer a structural allograft.
Metal Resurfacing Implants
A talar metallic inlay implant has been developed for treatment of localized OLTs of the medial dome. 79 This implant consists of 15 different offset sizes that are designed to reduce pain and decrease cyst formation. The optimal implantation depth is 0.5 mm below the level of the articular surface in order to decrease the chances of protrusion, which leads to increased tibial contact pressures. If the implant was too deep, adjacent cartilage may collapse. 41 Only one study has looked at the outcomes following implantation of this device. 78 van Bergen et al prospectively studied 20 patients treated with this metallic inlay device for a mean of 3 years. Postoperatively, there was statistically significant reduction of pain at rest and while walking, stair climbing and running. The median AOFAS anklehindfoot score significantly improved from 62 to 87 at final followup. The mean shortform 36 physical component scale improved significantly while the mental component scale did not change significantly. One patient required additional surgery for the osteochondral defect. On plain Xrays, progressive degeneration of the opposite tibial plafond was seen in two patients.
CONCLUSION
Osteochondral lesions of the talus remain a treatment challenge despite the many surgical treatment strategies available. In general, treatment options can be classified as cartilage repair, regeneration or replacement but not all treatment options are available worldwide. The multitude of approaches is in part due to the variable characteristics of OLTs and the lack of treatment comparison studies. Although the majority of reports in the literature are level IV evidence studies, results are generally favorable but firm treatment recommen dations are unable to be made. A basic algorithm that the authors use for surgical treatment of OLTs is outlined in Flow Chart 1. However, the final decision on treatment strategy must be based on available data, availability/approval and surgeon comfort.
